Scinai Immunotherapeutics SCNI
NASDAQ SCNI
$3.22 +0.28 (+9.52%)
At close: Aug 21, 2026 · 4:00 PM EDT

Scinai Immunotherapeutics (SCNI) Retained Earnings (2015 - 2026)

Scinai Immunotherapeutics (SCNI) posted Retained Earnings of -$122.3 million for Q1 2026, up 2.84% sequentially from -$125.8 million in Q4 2025.

Scinai Immunotherapeutics (SCNI) Retained Earnings (2015 - 2026) Analysis & Trends

Scinai Immunotherapeutics has reported Retained Earnings for 12 years, with the latest figure at -$122.3 million in Q1 2026.

  • Quarterly Retained Earnings changed N/A year-over-year to -$122.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$122.3 million (changed N/A YoY) and the FY2025 annual result came in at -$125.8 million, down 201.79% from the prior year.
  • Retained Earnings climbed to -$122.3 million in Q1 2026 per SCNI's latest filing, from -$125.8 million in the prior quarter.
  • Over five years, Retained Earnings peaked at $123.6 million in Q4 2024 and troughed at -$126.8 million in Q2 2024.
  • A 5-year average of -$87.9 million and a median of -$120.0 million in 2023 frame the typical range for Retained Earnings.
  • The sharpest annual moves came in 2023 and 2024: Retained Earnings tumbled 205.39% in 2023, then surged 201.06% in 2024.
  • Over 5 years, Retained Earnings stood at $116.1 million in 2022, then sank by 205.39% to -$122.3 million in 2023, then soared by 201.06% to $123.6 million in 2024, then sank by 201.79% to -$125.8 million in 2025, then increased by 2.84% to -$122.3 million in 2026.
  • According to Business Quant data, Retained Earnings over the past three periods registered -$122.3 million, -$125.8 million, and -$121.7 million for Q1 2026, Q4 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 15.69 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 37.62 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 558.00 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 5.10 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 13.05 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -6.33 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 20.91 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 6.57 Bn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 4.38 Bn
10 Scinai Immunotherapeutics 11.72 Mn -3.10 Bn -1.12 Mn -122.27 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -122.27 Mn
Dec 31, 2025 -125.85 Mn
Jun 30, 2025 -121.67 Mn
Dec 31, 2024 123.63 Mn
Sep 30, 2024 -115.31 Mn
Jun 30, 2024 -126.82 Mn
Mar 31, 2024 -124.49 Mn
Dec 31, 2023 -122.34 Mn
Sep 30, 2023 -120.01 Mn
Jun 30, 2023 -123.11 Mn
Mar 31, 2023 -119.35 Mn
Dec 31, 2022 116.08 Mn
Sep 30, 2022 -108.18 Mn
Jun 30, 2022 -110.58 Mn
Mar 31, 2022 -117.82 Mn
Dec 31, 2021 113.08 Mn
Sep 30, 2021 -109.64 Mn
Jun 30, 2021 -344.97 Bn
Mar 31, 2021 -332.98 Bn
Dec 31, 2020 -324.79 Bn